Kathleen Mullane, MD

University of Chicago Medical CenterChicago, Illinois - 60637 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2009

Dose-escalation Study of the Safety Tolerability and Ability of CMX001 to Prevent or Control Cytomegalovirus (CMV) Infection in R+ Hematopoietic Stem Cell Transplant Recipients
October 2009 - October 2011
Cytomegalovirus Infections
Placebo
Cmx001



